Cardiac Biotech Solutions, Inc. (OTCMKTS:CBSC) Sees Significant Growth in Short Interest

Cardiac Biotech Solutions, Inc. (OTCMKTS:CBSCGet Free Report) saw a significant increase in short interest in the month of May. As of May 15th, there was short interest totaling 4,952 shares, an increase of 310.3% from the April 30th total of 1,207 shares. Approximately 0.0% of the company’s shares are sold short. Based on an average daily volume of 57,168 shares, the short-interest ratio is presently 0.1 days.

Cardiac Biotech Solutions Stock Performance

CBSC opened at $0.03 on Friday. The firm’s fifty day moving average is $0.03 and its two-hundred day moving average is $0.04. Cardiac Biotech Solutions has a twelve month low of $0.02 and a twelve month high of $0.06.

About Cardiac Biotech Solutions

(Get Free Report)

CB Scientific, Inc, through its US and international subsidiaries, provides innovative products and services in the ambulatory non-invasive cardiac monitoring space. Our FDA and CE cleared EKG devices, interactive cloud-based acquisition software, and smartphone apps for both iOS and Android platforms, provide improved compliance for patients at risk of abnormal heart rhythms as well as more accurate information for physicians.

See Also

Receive News & Ratings for Cardiac Biotech Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiac Biotech Solutions and related companies with MarketBeat.com's FREE daily email newsletter.